Bradley Dickerson

Bradley Dickerson is a seasoned professional in the pharmaceutical industry, specializing in commercial functions for global companies with a focus on rare diseases.

Currently serving as the Chief Commercial Officer at Palvella Therapeutics, Bradley spearheads the development and implementation of commercial strategies for potential new product launches.

With a wealth of experience in senior leadership roles at prestigious companies like Aurinia Pharmaceuticals, Shire, and NPS Pharmaceuticals, Bradley excels in building high-performing teams and driving successful commercialization.

His expertise spans marketing strategy, market access, pricing, sales force deployment, patient services, and more, enabling him to transform small companies into successful market players.

Bradley's passion for serving the end customer, commitment to excellence, and mentorship from industry experts contribute to his outstanding performance and ability to deliver exceptional results.

Known for his accountability, servant leadership, and innovative vision, Bradley cultivates a culture of performance and empowerment in the organizations he engages with.

Bradley Dickerson holds degrees in Business Administration and Management, and has held prominent positions such as Vice President of Project Management & Patient Advocacy at iECURE, Inc., and President at BJD Life Science Consulting.

His professional journey includes key roles in various pharmaceutical companies, where he has honed his skills in new business development, product forecasting, contract negotiations, and specialty drugs among other areas.

Bradley's commitment to making a difference in the pharmaceutical industry, particularly in the realm of rare diseases, is evident through his impactful work and strategic leadership.

To connect with Bradley Dickerson and learn more about his work with Palvella Therapeutics, visit his LinkedIn profile.